Editing Jianqin Lu
Jump to navigation
Jump to search
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
| Latest revision | Your text | ||
| Line 9: | Line 9: | ||
=== Biography === | === Biography === | ||
Dr. Lu obtained his Ph.D. from [[The University of Pittsburgh]] and from 2019 started working at [[The University of Arizona]]. The overarching goal of the Lu research Laboratory <Ref>{{cite web|url=https://caoabgail.wixsite.com/jianqinlu|title=Jianqin Lu|publisher=Jianqin Lu Laboratory}}</ref> is to apply synthetic chemistry, [[nanoparticle]] engineering, and [[tumor immunology]] to develop safe and efficacious [[nanotherapeutics]] to address the pressing unmet needs in current [[cancer therapy]], particularly in the emerging field of combination immunochemotherapy. The Lu Lab's expertise in [[Pharmaceutics]], [[Drug Delivery]], [[Nanomedicine]] and [[Tumor]] [[Immunology]] paves the way to develop transformative and clinically translatable nanoimmunotherapeutics for combatting cancers. Dr. Lu was the recipient of the Norman R. and Priscilla A. Farnsworth Award, and USHHS Ruth L. Kirschstein Institutional National Research Service Award in Tumor Immunology, among others. | Dr. Lu obtained his Ph.D. from [[The University of Pittsburgh]] and from 2019 started working at [[The University of Arizona]]. The overarching goal of the Lu research Laboratory <Ref>{{cite web|url=https://caoabgail.wixsite.com/jianqinlu|title=Jianqin Lu|publisher=Jianqin Lu Laboratory}}</ref> is to apply synthetic chemistry, [[nanoparticle]] engineering, and [[tumor immunology]] to develop safe and efficacious [[nanotherapeutics]] to address the pressing unmet needs in current [[cancer therapy]], particularly in the emerging field of combination immunochemotherapy. The Lu Lab's expertise in [[Pharmaceutics]], [[Drug Delivery]], [[Nanomedicine]] and [[Tumor]] [[Immunology]] paves the way to develop transformative and clinically translatable nanoimmunotherapeutics for combatting cancers. Dr. Lu was the recipient of the Norman R. and Priscilla A. Farnsworth Award, and USHHS Ruth L. Kirschstein Institutional National Research Service Award in Tumor Immunology, among others. | ||
| − | Dr. Lu was featured in BIO5 Institute Science Talk Podcast <ref>{{cite web|url=https://www.youtube.com/watch?v=hwEWVDG0n4A|title=Jianqin Lu|publisher=BIO5 Institute Science Talk Podcast}}</ref> <ref>{{cite web|url=https://anchor.fm/bio5sciencetalks/episodes/Episode-2-Science-Talks-with-Dr--Jianqin-Lu-epumoa|title=Jianqin Lu|publisher=Anchor by Spotify: Science Talks}}</ref>and was interviewed by [[KVOA]] - News4Tucson <ref>{{cite web|url=https://caoabgail.wixsite.com/jianqinlu/about-lab|title=Jianqin Lu|publisher=KVOA - News4Tucson Interview}}</ref> to discuss the research efforts on developing safer and more effective drugs for the fight against | + | Dr. Lu was featured in BIO5 Institute Science Talk Podcast <ref>{{cite web|url=https://www.youtube.com/watch?v=hwEWVDG0n4A|title=Jianqin Lu|publisher=BIO5 Institute Science Talk Podcast}}</ref> <ref>{{cite web|url=https://anchor.fm/bio5sciencetalks/episodes/Episode-2-Science-Talks-with-Dr--Jianqin-Lu-epumoa|title=Jianqin Lu|publisher=Anchor by Spotify: Science Talks}}</ref>and was interviewed by [[KVOA]] - News4Tucson <ref>{{cite web|url=https://caoabgail.wixsite.com/jianqinlu/about-lab|title=Jianqin Lu|publisher=KVOA - News4Tucson Interview}}</ref> to discuss the research efforts on developing safer and more effective drugs for the fight against COVID-19. |
| − | In addition, he is a [[Steelers]] fan. | + | In addition, he is a [[Steelers]] fan. |
=== Reference=== | === Reference=== | ||
Advertising:
